Health Canada has approved the primary vaccine for respiratory syncytial virus (RSV) for adults age 60 and over, however it may only be …
A key step forward for Novo Nordisk’s GLP-1 pill
Novo Nordisk flags flutter outside their office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, July 14, 2025. Tom Little...






